Patents by Inventor Ben ESQUE

Ben ESQUE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND COMPOSITIONS FOR TREATING EDEMA REFRACTORY TO ORAL DIURETICS
    Publication number: 20250032436
    Abstract: The present invention features methods and compositions for the intranasal, sublingual, and subcutaneous administration of bumetanide for the treatment of subjects suffering from edema refractory to oral diuretics.
    Type: Application
    Filed: October 15, 2024
    Publication date: January 30, 2025
    Inventors: Balasingam RADHAKRISHNAN, Ben ESQUE, Wei LIN, Andrew Xian CHEN
  • Methods and compositions for treating edema refractory to oral diuretics
    Patent number: 12150923
    Abstract: The present invention features methods and compositions for the intranasal, sublingual, and subcutaneous administration of bumetanide for the treatment of subjects suffering from edema refractory to oral diuretics.
    Type: Grant
    Filed: February 25, 2022
    Date of Patent: November 26, 2024
    Assignee: RESQ Pharmaceuticals LLC
    Inventors: Balasingam Radhakrishnan, Ben Esque, Wei Lin, Andrew Xian Chen
  • SUBCUTANEOUS FORMULATION AND METHODS FOR TREATING EDEMA REFRACTORY TO ORAL DIURETICS
    Publication number: 20240285566
    Abstract: The present invention features methods and compositions for the subcutaneous administration of bumetanide for the treatment of subjects suffering from edema refractory to oral diuretics.
    Type: Application
    Filed: June 9, 2022
    Publication date: August 29, 2024
    Inventors: Balasingam RADHAKRISHNAN, Ben ESQUE, Wei LIN, Andrew Xian CHEN
  • METHODS AND COMPOSITIONS FOR TREATING EDEMA REFRACTORY TO ORAL DIURETICS
    Publication number: 20220287996
    Abstract: The present invention features methods and compositions for the intranasal, sublingual, and subcutaneous administration of bumetanide for the treatment of subjects suffering from edema refractory to oral diuretics.
    Type: Application
    Filed: February 25, 2022
    Publication date: September 15, 2022
    Inventors: Balasingam RADHAKRISHNAN, Ben ESQUE, Wei LIN, Andrew Xian CHEN
  • Methods and compositions for treating edema refractory to oral diuretics
    Patent number: 11260038
    Abstract: The present invention features methods and compositions for the intranasal, sublingual, and subcutaneous administration of bumetanide for the treatment of subjects suffering from edema refractory to oral diuretics.
    Type: Grant
    Filed: June 11, 2021
    Date of Patent: March 1, 2022
    Assignee: RESQ Pharmaceuticals LLC
    Inventors: Balasingam Radhakrishnan, Ben Esque, Wei Lin, Andrew Xian Chen
  • Methods and compositions for treating edema refractory to oral diuretics
    Patent number: 11123319
    Abstract: The present invention features methods and compositions for the intranasal, sublingual, and subcutaneous administration of bumetanide for the treatment of subjects suffering from edema refractory to oral diuretics.
    Type: Grant
    Filed: December 4, 2020
    Date of Patent: September 21, 2021
    Assignee: RESQ Pharmaceuticals LLC
    Inventors: Balasingam Radhakrishnan, Ben Esque, Wei Lin, Andrew Xian Chen
  • METHODS AND COMPOSITIONS FOR TREATING EDEMA REFRACTORY TO ORAL DIURETICS
    Publication number: 20210169833
    Abstract: The present invention features methods and compositions for the intranasal, sublingual, and subcutaneous administration of bumetanide for the treatment of subjects suffering from edema refractory to oral diuretics.
    Type: Application
    Filed: December 4, 2020
    Publication date: June 10, 2021
    Inventors: Balasingam RADHAKRISHNAN, Ben ESQUE, Wei LIN, Andrew Xian CHEN